Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 5 of 5 entries
View as:

A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02239354 Org: User:
Start: 09/30/14 End: 12/31/17 Due: 12/31/18

A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT04678557 Org: User:
Start: 06/25/19 End: 11/19/21 Due: 11/19/22

A Safety and Tolerability Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03162926 Org: User:
Start: 07/05/17 End: 02/15/18 Due: 02/15/19

A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness

Phase: N/A Priority: Normal
NCT ID: NCT03163511 Org: User:
Start: 07/06/17 End: 10/19/23 Due: 10/19/24

One-Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™

Phase: N/A Priority: Normal
NCT ID: NCT02939118 Org: User:
Start: 11/07/16 End: 02/08/24 Due: 02/08/25